Filing Details
- Accession Number:
- 0001654954-19-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-03 19:21:20
- Reporting Period:
- 2018-12-31
- Accepted Time:
- 2019-01-03 19:21:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001316 | Tg Therapeutics Inc. | TGTX | Pharmaceutical Preparations (2834) | 363898269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1538845 | A Sean Power | 2 Gansevoort St, 9Th Floor New York NY 10011 | Cfo, Secretary And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-01-02 | 37,275 | $4.13 | 400,992 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2018-12-31 | 115,000 | $0.00 | 115,000 | $4.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
115,000 | 2028-12-31 | No | 4 | A | Direct |
Footnotes
- In connection with the vesting of 72,500 shares on January 1, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- Represents the weighted average sales price.
- Includes shares of restricted Common Stock, which are subject to vesting.
- The options vest according to the following schedule: 25% on each of January 1, 2020, January 1, 2021, January 1, 2022, and January 1, 2023.